Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
2.560
+0.110 (4.49%)
At close: Dec 24, 2025, 1:00 PM EST
2.511
-0.050 (-1.93%)
After-hours: Dec 24, 2025, 4:53 PM EST
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $89.71 million as of December 24, 2025. Its market cap has increased by 2,583.19% in one year.
Market Cap
89.71M
Enterprise Value
82.30M
1-Year Change
2,583.19%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has increased from $41.18M to $89.71M, an increase of 117.85%. That is a compound annual growth rate of 21.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 85.86M | 2,087.22% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
| Jan 12, 2022 | 41.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |